MALAT1 and prostate cancer: Increased expression of MALAT1 was first observed in metastatic non-small cell lung cancer [15], followed by endometrial stromal sarcoma of the uterus [33], and more recently in six other types of cancer, including HCC, breast, pancreas, lung, colon, and prostate cancers [34].